The Goa Institute of Management (GIM), the implementation of a two-day symposium to study the impact of patents on the maturity of the pharmaceutical industry, 20 and August 21, 2005, in Goa.

The symposium aims to examine the changing economic conditions for the Indian industry by the introduction of the product patent regime from 1 January 2005.

The theme and the structure of discussions at the seminar are as follows:

Economic, social and legal implications of the introduction of TRIPs (Trade-Related Aspects of Intellectual Property Rights).

Effects of the implementation of TRIPs on models of majors in India.

Identification of possible business opportunities and competition of the benefits arising from the changing business scenario.

Evolving a policy support, which would be a guide for policy makers and regulators in the indication of guidelines for the industry.

During the two-day symposium, a number of distinguished speakers from the industry for its views on the question above. These include:

Padmabhushan Dr Anil Kakodkar, Chairman of the Atomic Energy Commission

Dr. Padmashri nr Madhav Menon, director of support, Expert Committee on Patents and IPR –

Dr T Ramakrishna, director of CIPRA, NLSIU

S Ramakrishna, Sr. Director, Corp. Affairs, Pfizer India

Dr Prakash modes, Chairman & MD, Unichem Labs

Pradip Mazumdar, exec Director, Syngenta

Dr. Arno Hartmann, Director, Division Patent KGaA, Merck, Germany

Padmashri Dr. K. Anji Reddy, Chairman, Dr. Reddy’s Labs

Dr. Swati Piramal, director, Nicholas Piramal

Ravindra Limaye, VP, Business Development, GSK

Dr Girish L Telang, MD, Roche, India and a number of other dignitaries.

GIM (Goa Institute of Management) was founded in 1993 as a centre of excellence for management training and research, through the initiative and support of some prominent citizens and business leaders and with support from the Government of Goa. In a short time, the first B-school GIM, to the west of India, and is among the best in the country